Home Cart Sign in  
Chemical Structure| 499-80-9 Chemical Structure| 499-80-9
Chemical Structure| 499-80-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

2,4-PDCA is a broad-spectrum 2OG oxygenase inhibitor used in studies of histone demethylases and bioplastics, serving as an important tool in chemical research.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations

Charles Izuchukwu Ezekiel ; Sanika Jadhav ; Lewis L. Stevens ; Leonard R. MacGillivray ;

Abstract: Cocrystals of 2,4-pyridinedicarboxylic acid (PDA) with either nicotinamide (NTD) or tranexamic acid (TXA) as (PDA)·(NTD) and 2(PDA)·(TXA), respectively, are reported, with the former being a molecular cocrystal and the latter being an ionic cocrystal. Single-crystal structure analyses showed that PDA and its coformers are sustained by neutral and ionic hydrogen bonds. Suspensions of (PDA)·(NTD) resulted in complete conversion to PDA monohydrate after 48 h, while 2(PDA)·(TXA) was thermodynamically stable at a lower pH and showed a 2-fold increase in the PDA concentration, relative to pure PDA monohydrate under similar conditions. Thermal characterization of 2(PDA)·(TXA) displayed a lower melting point and a lower heat of fusion, relative to the pure components. Powder dissolution studies were evaluated for PDA, (PDA)·(NTD), and 2(PDA)·(TXA) and the corresponding physical mixtures. The percent of PDA dissolved rapidly reached near 100% for most cases; however, for 2(PDA)·(TXA), complete dissolution was not achieved, and the amount of PDA dissolved decreased to 85% after 3 h. Instability of 2(PDA)·(TXA) was likely a result of a high solution pH during dissolution, and our results confirm that the solution pH plays a key role in determining the solution behavior and phase stability of the cocrystals.

Purchased from AmBeed: ;

Alternative Products

Product Details of 2,4-PDCA

CAS No. :499-80-9
Formula : C7H5NO4
M.W : 167.12
SMILES Code : O=C(C1=NC=CC(C(O)=O)=C1)O
MDL No. :MFCD00006296
InChI Key :MJIVRKPEXXHNJT-UHFFFAOYSA-N
Pubchem ID :10365

Safety of 2,4-PDCA

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Application In Synthesis of 2,4-PDCA

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 499-80-9 ]

[ 499-80-9 ] Synthesis Path-Upstream   1~1

  • 1
  • [ 499-80-9 ]
  • [ 24195-03-7 ]
References: [1] Chemistry - An Asian Journal, 2018, vol. 13, # 19, p. 2854 - 2867.
[2] Bioorganic and Medicinal Chemistry, 2019, vol. 27, # 6, p. 1119 - 1129.
 

Historical Records

Technical Information

Categories